Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone

This publication has 17 references indexed in Scilit:

• IN-VITRO GLUCOCORTICOID STUDIES FOR PREDICTING RESPONSE TO GLUCOCORTICOID THERAPY IN ADULTS WITH MALIGNANT LYMPHOMA
  The Lancet, 1980
• Clinical Trial of Prednimustine, Leo‐1031 (NSC‐134087), in Patients with Non‐Hodgkin Lymphomata and Chronic Lymphocytic Leukaemia Previously Treated with Steroids and Alkylating Agents
  Acta Medica Scandinavica, 1980
• Response to Therapy as Prognostic Factor in Chronic Lymphocytic Leukemia
  Acta Haematologica, 1980
• Does therapy alter the natural history and prognosis of chronic lymphocytic leukemia?
  International Journal of Radiation Oncology*Biology*Physics, 1979
• Continuous Treatment of Non-Hodgkin’s Malignant Lymphoma with Prednimustine (Leo 1031)
  Oncology, 1978
• Therapeutic effect of prednimustine (LEO 1031) in various types of leukaemia
  Published by Elsevier ,1977
• Evidence for a Glucocorticoid Receptor in Human Leukocytes
  Acta Physiologica Scandinavica, 1976
• THERAPEUTIC EFFECT OF LEO 1031, AN ALKYLATING CORTICOSTEROID ESTER, IN LYMPHOPROLIFERATIVE DISORDERS
  Acta Medica Scandinavica, 1975
• Studies of Leukocyte Kinetics in Chronic Lymphocytic Leukemia
  Blood, 1968
• A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
  Biometrika, 1965